D.A. Davidson & Co’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
D.A. Davidson & Co's ACLS Position: Q1 2026 in Review
D.A. Davidson & Co reduced its Axcelis (ACLS) stake by 13% in Q1 2026, selling an estimated $29.8K and leaving 2,300 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.
D.A. Davidson & Co first reported a position in ACLS in Q3 2022 and has held it in 9 quarters since. The position peaked at $413K in Q1 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- D.A. Davidson & Co held 2,300 shares of Axcelis worth $214K as of Q1 2026.
- D.A. Davidson & Co sold 337 Axcelis shares in Q1 2026, an estimated $29.8K.
- Axcelis made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #1468 holding.
- D.A. Davidson & Co first reported a position in Axcelis in Q3 2022 and has held it in 9 quarters since.
- D.A. Davidson & Co's Axcelis position peaked at $413K in Q1 2023.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.